Pharmacy-Benefit Consultant Speaks Out on Prescription-Drug Average Wholesale Price Issue
Posted on: Tuesday, 24 October 2006, 15:01 CDT
A recent article in the Wall Street Journal explained the impact of the settlement of a class-action lawsuit against First DataBank, the primary publisher of prescription-drug average wholesale prices.
Published AWP price points are used by private-sector plan sponsors and government programs to determine how much they reimburse pharmacies for dispensing drugs for their members and beneficiaries. The lawsuit against First DataBank uncovered information specific to its wholesaler survey methodology and a one-time increase of 5 percent for a specific subset of highly used prescription drugs.
"There are problems with AWP and how it is calculated. That situation needs to be remedied, and we need to look to the future and find a better solution to prevent something like this from happening again," said Brain Bullock, president and CEO of The Burchfield Group, a pharmacy-benefit consulting firm that helps employers and other plan sponsors control the costs of providing prescription drug coverage for their beneficiaries. "That said, finding the solution the market needs will not be an easy task."
For further discussion on the topic, visit www.burchfieldgroup.com and listen to today's installment of the Pharmacy Benefits Podcast, in which Bullock discusses this issue in depth and offers insight into how the industry can move beyond this issue.
Despite its flaws, there is currently no good substitute for average wholesale price as a benchmark for pricing prescription drugs in today's marketplace, according to Bullock. The Office of Inspector General, the Centers for Medicare and Medicaid Services (CMS) and other federal agencies and state governments have been working for several years to develop a replacement for AWP, Bullock says. While some progress has been made, nothing yet fits the mold of an acceptable substitute.
According to Bullock, any effective pricing system will have these qualities:
-- accurate and reliable -- generally and widely available -- current and up-to-date -- transparent and accessible
"With the uncertainly surrounding AWP, it is critical that we remember the importance of managing trend," Bullock said. "That's the critical end point in this business, and plan sponsors should not lose sight of the role plan design and other solutions play in controlling costs."
Bullock invites his podcast listeners to submit questions and comments, which he will address directly and in future podcasts. E-mail bbullock@burchfieldgroup.com or call 651-389-5640.
About The Burchfield Group
The Burchfield Group is a pharmacy benefit management consultancy based in St. Paul, Minn. The Burchfield Group brings innovative perspectives to managing pharmacy benefits, helping plan sponsors evaluate and select pharmacy benefit administration vendors, designing pharmacy benefit plans, monitoring plan and PBM performance, and auditing results. Its staff of experts has a vast knowledge of the PBM industry, including insight into drug manufacturers' influences, mail service profits and retail network margins.
Contact: Michael Keliher 651-695-0174 - office 651-324-0213 - cell mkeliher@providentpartners.net
SOURCE: The Burchfield Group
Source: MARKET WIRE
Related Articles
- Significant Cost Savings Point to Health Benefits of Integrated Prescription Drug Coverage
- New Internet Pharmacy Verification Program to Reduce Consumer Fraud, Prescription Drug Diversion
- NCPA-Pfizer Digest Preliminary Data Shows Independent Community Pharmacies Have Been Hurt By Medicare Part D Prescription Drug Plan
- Seniors Can Still Enroll in Medicare Health Plans, Even After May 15 Deadline; Medicare Advantage Enrollment Still Open; Plans May Save Seniors Money on Prescription Drugs
- National Association of Boards of Pharmacy Executive Director Testifies in Support of Prescription Drug Distribution Legislation
- Pharmacy Benefit Managers Oversee Prescription Drug Plans to Over 200 Million Americans
- PBMs' Efforts to Promote Generic Drugs, Mail-Service Pharmacies Pay Off in Historic Slowdown in Prescription-Drug Spending Growth
- Insurers Line Up to Offer Prescription Drug Benefit
- CORRECTING and REPLACING Health Net Expands Medicare Plan Offerings; Nearly 100 New Plans Key To Company's Cost-Effective Prescription Drug Coverage
- CVS Chief: Import Prescription Drugs
User Comments (0)

RSS Feeds